Ovarian Cancer

Posted On 2020-09-11 16:42:09


This series on “Ovarian Cancer” is edited by Heriberto Medina-Franco, MD, FACS, Department of Surgery, Section of Surgical Oncology, National Institute of Medical Sciences and Nutrition “Salvador Zubirán”, Mexico City, Mexico.

In the recent years, great advances in the knowledge and treatment of ovarian cancer has been made. In the present series of Chinese Clinical Oncology, a complete review of the recent advances in diagnosis and treatment of ovarian neoplasms has been performed.

Editorial on Ovarian Cancer
Up-to-date in ovarian cancer
Heriberto Medina-Franco

Review Article on Ovarian Cancer
Role of hyperthermic intraperitoneal chemotherapy in ovarian cancer
Juan Manuel Medina-Castro, Adriana Ruiz-DeLeón

Ovarian carcinoma: pathology review with an emphasis in their molecular characteristics
Leonardo S. Lino-Silva

Can lymphadenectomy be omitted in advanced ovarian cancer?—a brief review
Rosa A. Salcedo-Hernández

Epidemiology of ovarian cancer
Patricia Gaona-Luviano, Lourdes Adriana Medina-Gaona, Kassandra Magaña-Pérez

Fertility-sparing treatment for epithelial ovarian cancer: a literature review
Milagros Pérez-Quintanilla, Sarish del Real-Ordoñez, Lenny Gallardo-Alvarado, David Cantu-de Leon

Radiotherapy in women with epithelial ovarian cancer: historical role, current advances, and indications
Christian Haydeé Flores-Balcázar, Dulce María Urías-Arce

Non-epithelial ovarian carcinoma: what is the optimal staging surgery?
Heriberto Medina-Franco, Luis Enrique Colonna-Márquez

PARP inhibitors in ovarian cancer: evidence for maintenance and treatment strategies
Antonio Bahena-González, Alfredo Toledo-Leyva, Dolores Gallardo-Rincón

Systemic therapy for non-serous ovarian carcinoma
Yanin Chávarri-Guerra, Eduardo González-Ochoa, Héctor De-la-Mora-Molina, Enrique Soto-Perez-de-Celis

Controversies on the treatment of ovarian cancer with dose-dense chemotherapy
Alberto Súarez-Zaizar, Eduardo Cárdenas-Cárdenas, Yadira Araceli Barajas-Castro, Patricia Cortés-Esteban

How far should we go in optimal cytoreductive surgery for ovarian cancer?
Luis A. Hernandez-Lopez, Angel Elizalde-Mendez